Olympia Medical Center Neurosurgeon Performs First Spine Surgery Using PureGen Stem Cell Technology

Carl Lauryssen, MD, a neurosurgeon and director of research and education at Olympia Medical Center Los Angeles, completed the first procedure using Alphatec Spine’s PureGen, a highly concentrated, pure population of adult stem cells originating from bone marrow, according to a hospital news release.

Advertisement

Dr. Lauryssen performed the L4-S1 posterolateral fusion using the PureGen osteoprogenitor cell allograft from Alphatec Spine. PureGen is an adult stem cell that provides the osteogenic factors for bone remodeling. When applied to a musculoskeletal defect, PureGen increases the stem cells on the location, which promotes a regenerative environment.

Read the Olympia Medical Center release on PureGen.
http://www.onlineprnews.com/news/66366-1286307570-first-patient-procedure-in-the-world-using-adult-stem-cells-to-enhance-spine-surgery-outcome.html

Read other coverage on biologics in orthopedics:

– Spine Surgery Research Update: Biologics in Spine Surgery


– Beyond Traditional Surgery: Options for Knee Surgery With Better Outcomes


– Biologics: What Every Physician Should Understand Before Performing Treatment from Dr. James Gladstone of Mount Sinai medical Center

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spine

Advertisement

Comments are closed.